Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MDCO | The Medicines Co. | -0.05% | 84.03 | 20.1% | $614.99m | |
| AMRN | Amarin Corp. Plc | 0.13% | 22.84 | 1.7% | $318.94m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 6.63% | 31.28 | 14.1% | $184.06m | |
| ARQL | ArQule, Inc. | -0.97% | 20.01 | 0.6% | $136.94m | |
| SAGE | SAGE Therapeutics, Inc. | 2.94% | 70.69 | 8.6% | $121.05m | |
| BHC | Bausch Health Cos., Inc. | 6.63% | 31.28 | 0.0% | $115.60m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -3.23% | 115.51 | 16.9% | $91.79m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.65% | 149.09 | 2.3% | $91.14m | |
| GWPH | GW Pharmaceuticals Plc | 2.99% | 105.96 | 6.2% | $85.08m | |
| PRGO | Perrigo Co. Plc | 0.95% | 54.32 | 6.8% | $65.40m | |
| AXSM | Axsome Therapeutics, Inc. | 2.31% | 49.18 | 2.0% | $60.85m | |
| HZNP | Horizon Therapeutics Plc | 2.36% | 33.01 | 6.6% | $43.86m | |
| ICLR | ICON plc | -0.17% | 161.46 | 4.2% | $43.09m | |
| UTHR | United Therapeutics Corp. | 0.34% | 92.80 | 14.3% | $35.89m | |
| ENDP | Endo International Plc | 7.06% | 4.70 | 8.8% | $33.53m |
Company Profile
SAGE Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.